journal article·2025-03-05Open access

Long-Term Safety Evaluation of Fluorescent Gold Nanoclusters Conjugated with α-Lipoic Acid: Insights from a Six-Month In Vivo Study

Yu-Wei Lai, Yi-Nan Lee, Hung-I Yeh, Yih-Jer Wu, Wen-Hsiung Chan, Shih-Wei Wang, Chao-Feng Lin, Chun-Hsuan Lin, Yun-Fang Chen, Ching-Hu Chung

Abstract

Background: Fluorescent gold nanoclusters conjugated with α-lipoic acid (FANCs) have shown great promise for drug development. In a previous study, FANCs did not show any acute or subacute toxicity under 0.6–20 μM/100 μL/25 g body weight in male and female ICR mice. However, the chronic toxicity of FANCs has not been studied. Aim of study: This study used oral administration of FANCs to determine the long-term safety profile and adverse effects in ICR mice. Methods: In vivo chronic toxicity was examined via oral administration of FANCs to male and female ICR mice. The daily food consumption, body weight, hematological profile, serum biochemical profile, organ coefficient, histopathological changes, and survival rate of the mice were calculated. Results: FANCs did not result in mortality due to chronic toxicity in both male and female mice. The animal behavior, body weight, hematological profile, serum biochemical profile, and organ coefficient showed no treatment-related malignant changes. This indicates that FANCs do not cause liver, renal, or other organ damage. Conclusions: These results indicate that the no-observed-adverse-effect level (NOAEL) is 20 μM/100 μL/25 g for 6 months of treatment in male and female ICR mice.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanocluster Synthesis and Applications · Alzheimer's disease research and treatments · Biochemical Acid Research Studies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Center of General Education, University of Taipei, Taipei 100, Taiwan

Division of Urology, Taipei City Hospital Renai Branch, Taipei 106, Taiwan

Cardiovascular Center, Department of Internal Medicine, MacKay Memorial Hospital, Taipei 104, Taiwan

Department of Medicine, MacKay Medical College, New Taipei City 252, Taiwan

Department of Bioscience Technology and Center for Nanotechnology, Chung Yuan Christian University, Zhongbei Road, Zhongli District, Taoyuan City 320, Taiwan

Institute of Biomedical Sciences, MacKay Medical College, New Taipei City 252, Taiwan

Funding

National Science and Technology Council in Taiwan · Mackay Medical College in Taiwan · Taipei City Hospital in Taiwan

References (35)

Show source-provided references
1. Oliveira, B.B., Ferreira, D., Fernandes, A.R., and Baptista, P.V. (2023). Engineering gold nanoparticles for molecular diagnostics and biosensing. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 15.10.1002/wnan.1836 ↗
2. Prostate-specific membrane antigen targeted gold nanoparticles for prostate cancer radiotherapy: Does size matter for targeted particles?10.1039/C9SC02290B ↗
3. Gold Nanoclusters: Imaging, Therapy, and Theranostic Roles in Biomedical Applications10.1021/acs.bioconjchem.1c00475 ↗
4. Amphiphilic modification and asymmetric silica encapsulation of hydrophobic Au-Fe3O4 dumbbell nanoparticles10.1039/C3CC47634K ↗
5. Entrapment of hydrophobic drugs in nanoparticle monolayers with efficient release into cancer cells10.1021/ja808137c ↗
6. Atomically Precise Clusters of Noble Metals: Emerging Link between Atoms and Nanoparticles10.1021/acs.chemrev.6b00769 ↗
7. A trail of research from lipoic acid to alpha-keto acid dehydrogenase complexes10.1074/jbc.R100026200 ↗
8. Substrate channelling in 2-oxo acid dehydrogenase multienzyme complexes10.1042/bst0300047 ↗
9. Lipoic acid—The drug of the future?
10. Alpha-lipoic Acid: An Antioxidant with Anti-aging Properties for Disease Therapy10.2174/0109298673300496240416114827 ↗
11. Synthesis, characterization, and bioconjugation of fluorescent gold nanoclusters toward biological labeling applications10.1021/nn800632j ↗
12. Lee, Y.N., Wu, Y.J., Su, C.H., Wang, B.J., Yang, S.H., Lee, H.I., Chou, Y.H., Tien, T.Y., Lin, C.F., and Chan, W.H. (2024). Fluorescent gold nanoclusters possess multiple actions against atherosclerosis. Redox Biol., 78.10.1016/j.redox.2024.103427 ↗
13. alpha-Lipoic acid ameliorates foam cell formation via liver X receptor alpha-dependent upregulation of ATP-binding cassette transporters A1 and G110.1016/j.freeradbiomed.2010.10.706 ↗
14. Alpha-lipoic acid ameliorates H2O2-induced human vein endothelial cells injury via suppression of inflammation and oxidative stress10.1080/09168451.2020.1802221 ↗
15. Application of gold nanoparticles in biomedical researches and diagnosis10.7754/Clin.Lab.2012.120614 ↗
16. Nanotheranostic Application of Fluorescent Protein-Gold Nanocluster Hybrid Materials: A Mini-review10.7150/ntno.58060 ↗
17. Zhang, B., Chen, J., Cao, Y., Chai, O.J.H., and Xie, J. (2021). Ligand Design in Ligand-Protected Gold Nanoclusters. Small, 17.10.1002/smll.202004381 ↗
18. Gold nanocluster-based fluorescent sensors for in vitro and in vivo ratiometric imaging of biomolecules10.1039/D3CP02714G ↗
19. A Review on Gold Nanoclusters for Cancer Phototherapy10.1021/acsabm.3c00518 ↗
20. Antimicrobial Gold Nanoclusters10.1021/acsnano.7b02035 ↗
21. Bailly, A.L., Correard, F., Popov, A., Tselikov, G., Chaspoul, F., Appay, R., Al-Kattan, A., Kabashin, A.V., Braguer, D., and Esteve, M.A. (2019). In vivo evaluation of safety, biodistribution and pharmacokinetics of laser-synthesized gold nanoparticles. Sci. Rep., 9.10.1038/s41598-019-48748-3 ↗
22. Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats10.1016/j.biomaterials.2009.11.079 ↗
23. Fluorescent gold nanoclusters as a biocompatible marker for in vitro and in vivo tracking of endothelial cells10.1021/nn102752a ↗
24. Wang, H.H., Lin, C.J., Tseng, Y.M., Lee, H.I., Lee, Y.N., Yeh, H.I., Yang, P.S., Peng, H.Y., and Wu, Y.J. (2021). Dihydrolipoic acid-coated gold nanocluster bioactivity against senescence and inflammation through the mitochondria-mediated JNK/AP-1 pathway. Nanomedicine, 36.10.1016/j.nano.2021.102427 ↗
25. Dihydrolipoic Acid-Gold Nanoclusters Regulate Microglial Polarization and Have the Potential to Alter Neurogenesis10.1021/acs.nanolett.9b04216 ↗
26. Controlled assembly of biodegradable plasmonic nanoclusters for near-infrared imaging and therapeutic applications10.1021/nn9015746 ↗
27. Chen, Y.F., Hsu, C.C., and Chung, C.H. (2022). Acute and Subacute Toxicity of Fluorescent Gold Nanoclusters Conjugated with alpha-Lipoic Acid. Nanomaterials, 12.10.3390/nano12213868 ↗
28. Gender-based differences in the toxicity of pharmaceuticals—The Food and Drug Administration’s perspective10.1080/109158101317097728 ↗
29. Mennecozzi, M., Landesmann, B., Palosaari, T., Harris, G., and Whelan, M. (2015). Sex differences in liver toxicity-do female and male human primary hepatocytes react differently to toxicants in vitro?. PLoS ONE, 10.10.1371/journal.pone.0122786 ↗
30. Sun, P.P., Lai, C.S., Hung, C.J., Dhaiveegan, P., Tsai, M.L., Chiu, C.L., and Fang, J.M. (2021). Subchronic oral toxicity evaluation of gold nanoparticles in male and female mice. Heliyon, 7.10.1016/j.heliyon.2021.e06577 ↗
31. Gershenson, D.M., Lentz, G.M., Valea, F.A., and Lobo, R.A. (2021). Comprehensive Gynecology, Elsevier. [8th ed.]. eBook.
32. Brown, J., and Farquhar, C. (2016). Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome. Cochrane Database Syst. Rev., 12.10.1002/14651858.CD002249.pub5 ↗
33. Cole, L.A., and Butler, S.A. (2022). Human Gonadotropins, Elsevier. eBook.
34. Cibas, E.S., and Ducatman, B.S. (2014). Cytology-Diagnostic Principles and Clinical Correlates, Saunders. eBook.
35. Monroe, G.R., van Eerde, A.M., Tessadori, F., Duran, K.J., Savelberg, S.M.C., van Alfen, J.C., Terhal, P.A., van der Crabben, S.N., Lichtenbelt, K.D., and Fuchs, S.A. (2019). Identification of human D lactate dehydrogenase deficiency. Nat. Commun., 10.10.1038/s41467-019-09458-6 ↗